FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas

Breyanzi is the first agent with an RMAT designation to be licensed by the FDA.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news